Published in J Exp Med on July 01, 1980
Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J Clin Invest (1982) 1.41
In vitro induction of cytologic and functional differentiation of the immature human monocytelike cell line U-937 with phorbol myristate acetate. Am J Pathol (1985) 1.34
Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses. Infect Immun (1984) 1.04
Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines. J Clin Invest (1983) 1.02
Chemotactic responses of various differentiational stages of neutrophils from human cord and adult blood. Infect Immun (1982) 0.98
Induction of selective biological responses to chemoattractants in a human monocyte-like cell line. Infect Immun (1983) 0.94
Appearance of chemotactic responsiveness to elastin peptides by developing fetal bovine ligament fibroblasts parallels the onset of elastin production. J Cell Biol (1984) 0.90
Interactions between alveolar macrophage subpopulations modulate their migratory function. Am J Pathol (1990) 0.88
Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages. Bioconjug Chem (2007) 0.86
Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine. Infect Immun (1982) 0.86
Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease. Dig Dis Sci (1988) 0.84
Chemotactic factor-induced polarization, receptor redistribution, and locomotion of human blood monocytes. Immunology (1988) 0.83
Specific effects on human neutrophils of antibodies to a membrane protein constituent of neutrophil receptors for chemotactic formyl-methionyl peptides. Immunology (1982) 0.80
Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation. J Biomed Sci (2017) 0.75
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med (1955) 13.98
N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24
The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim Biophys Acta (1952) 8.03
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun (1977) 3.81
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08
Transport of sodium, potassium, and calcium across rabbit polymorphonuclear leukocyte membranes. Effect of chemotactic factor. J Cell Biol (1977) 3.00
Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils. J Biol Chem (1979) 2.31
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J Immunol (1973) 2.18
In vitro activation of a human macrophage-like cell line. Nature (1979) 2.05
The beta-adrenergic receptor and adenylate cyclase. Biochim Biophys Acta (1976) 2.02
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
Phospholipid methylation in macrophages is inhibited by chemotactic factors. Proc Natl Acad Sci U S A (1979) 1.19
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol (1975) 4.10
Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science (1968) 3.69
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg (1986) 3.54
Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet (1984) 3.54
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35
Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med (1968) 3.33
Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science (1985) 3.27
rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem (1989) 3.21
Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99
Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol (1988) 2.91
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
A method of analysis of a certain class of experiments in carcinogenesis. Biometrics (1966) 2.86
Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Proc Soc Exp Biol Med (1969) 2.76
Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ (1997) 2.71
Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol (1991) 2.67
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest (1976) 2.58
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol (1969) 2.54
A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase. Science (1984) 2.53
Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med (1979) 2.51
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
The long-term prognosis of severe infantile malnutrition. Lancet (1967) 2.44
Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43
Toward the primary prevention of cancer. Science (1991) 2.41
Calcium influx requirement for human neutrophil chemotaxis: inhibition by lanthanum chloride. Science (1976) 2.34
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics (1978) 2.32
An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med (1980) 2.32
Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J Immunol (1973) 2.18
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
A chemotactic factor for mononuclear leukocytes. Proc Soc Exp Biol Med (1971) 2.18
Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol (1969) 2.18
Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis (1995) 2.18
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med (1971) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol (1976) 2.11
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Molecular and cellular mechanisms of leukocyte chemotaxis. Science (1981) 2.07
Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. J Immunol (1980) 2.06
Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. Biometrics (1968) 2.06
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
In vitro activation of a human macrophage-like cell line. Nature (1979) 2.05
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
Chemoattractant receptor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate in human polymorphonuclear leukocyte membranes. Requirement for a guanine nucleotide regulatory protein. J Biol Chem (1985) 2.03
A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet (1973) 2.02
Chemoattractant receptors on phagocytic cells. Annu Rev Immunol (1984) 2.01
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99
Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem (1997) 1.98
The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg (1986) 1.90
Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. J Immunol (1972) 1.90
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87
Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87
Slow mortality rate accelerations during aging in some animals approximate that of humans. Science (1990) 1.86
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
Long survivals in acute leukaemia. Lancet (1973) 1.85
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res (1993) 1.82
Potential role for a guanine nucleotide regulatory protein in chemoattractant receptor mediated polyphosphoinositide metabolism, Ca++ mobilization and cellular responses by leukocytes. Biochem Biophys Res Commun (1985) 1.82
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer (1991) 1.81
Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol (1977) 1.81
Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science (1986) 1.81
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
An inhibitor of macrophage chemotaxis produced by neoplasms. Science (1976) 1.79
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77